|
Thursday, November 20, 2008 [
11:38 PM ] |
Welcome guest (
Register | Login ) |
|
 |
 |
|
|
|
 |
| |
|
Story Tools
|
RELATED LINKS
|
Thalassemia
Thalassemia is an inherited disease of faulty synthesis of hemoglobin. The
name is derived from the Greek word "thalassa" meaning "the sea" because the
condition was first described in populations living near the Mediterranean Sea;
however, the disease is also prevalent in Africa, the Middle East, and Asia.
Thalassemia consists of a group of disorders that may range from a barely detectable
abnormality of blood, to severe or fatal anemia. Adult hemoglobin is composed
of two alpha (a) and two beta (ß) polypeptide chains. There are two copies of
the hemoglobin alpha gene (HBA1 and HBA2), which each encode an a-chain, and
both genes are located on chromosome 16. The hemoglobin beta gene (HBB) encodes
the ß-chain and is located on chromosome 11. In a-thalassemia, there is deficient
synthesis of a-chains. The resulting excess of ß-chains bind oxygen poorly,
leading to a low concentration of oxygen in tissues (hypoxemia). Similarly,
in ß- thalassemia there is a lack of ß-chains. However, the excess a-chains
can form insoluble aggregates inside red blood cells. These aggregates cause
the death of red blood cells and their precursors, causing a very severe anemia.
The spleen becomes enlarged as it removes damaged red blood cells from the circulation.
Deletions of HBA1 and/or HBA2 tend to underlie most cases of a-thalassemia.
The severity of symptoms depends on how many of these genes are lost. Loss of
one or two genes is usually asymptomatic, whereas deletion of all four genes
is fatal to the unborn child. In contrast, over 100 types of mutations affect
HBB, and deletion mutations are rare. Splice mutations and mutations that occur
in the HBB gene promoter region tend to cause a reduction, rather than a complete
absence, of ß-globin chains and so result in milder disease. Nonsense mutations
and frameshift mutations tend to not produce any ß- globin chains leading to
severe disease. Currently, severe thalassemia is treated by blood transfusions,
and a minority of patients are cured by bone marrow transplantation. Mouse models
are proving to be useful in assessing the potential of gene therapy.
For Diagnosis and treatment click
here
Important Links Gene sequence LocusLink [www.ncbi.nlm.nih.gov/LocusLink/list.cgi?Q=thalassemia&ORG=Hs&V=0]
collection of gene-related information BLink a-chain [www.ncbi.nlm.nih.gov/sutils/blink.cgi?pid=122412&org=1]
BLink ß-chain [www.ncbi.nlm.nih.gov/sutils/blink.cgi?pid=4504349&all=1]
related sequences in different organisms OMIM [www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=604131]
Note: hematology
|
| |
|
|
| |
|
Posted by: drnoush on Monday, May 17, 2004 - 06:47 PM |
|
|
 |
 |
 |
|
 |
 |
|
| Related Articles: | Keywords: hematology |
| Porphyria | Monday, May 17, 2004 | | Paroxysmal Nocturnal Hemoglobinuria | Monday, May 17, 2004 | | Niemann-Pick disease | Monday, May 17, 2004 | | Leukemia, chronic myeloid | Monday, May 17, 2004 | | Hemophilia A | Monday, May 17, 2004 | | Gaucher disease | Monday, May 17, 2004 | | Anemia, sickle cell | Monday, May 17, 2004 | | Burkitt lymphoma in Children | Monday, May 17, 2004 | | Anemia – Iron deficiency | Saturday, May 15, 2004 | | Anemia G6PD deficiency | Tuesday, May 11, 2004 | | More Related Articles... | Total: 12 Related Articles |
| Thalassemia | Login/Create an account | 0 Comments |
|
| | Comments are owned by the poster. We aren't responsible for their content. |
|
|